RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

This study is testing a new nasal spray vaccine called BLB-201 to see if it is safe and can help protect infants and young children from Respiratory Syncytial Virus (RSV). The trial will enroll 137 healthy children aged 8 months to 5 years, some who have had RSV before and some w…

This study is testing a new vaccine designed to protect against Respiratory Syncytial Virus (RSV) in Chinese adults aged 18 to 59 who have certain health conditions that put them at higher risk for severe RSV illness. Researchers will give a single dose of the vaccine to 750 part…

This study is testing an oral drug called S-337395 to see if it can help adults with RSV who are at high risk for severe illness. The goal is to see if the drug can reduce the amount of virus in the body and help people feel better faster. Participants are adults with recent RSV …

This study is testing whether the antibiotic azithromycin can help children under 2 years old who are hospitalized in intensive care with severe RSV lung infections. Researchers want to see if the medicine helps kids breathe easier and get out of the hospital and ICU sooner. The …

This study is testing a vaccine to prevent serious Respiratory Syncytial Virus (RSV) infections in adults who have received a lung or stem cell transplant. These patients have weakened immune systems and are at high risk from viruses like RSV. Researchers will give 100 participan…

This study is testing whether giving an extra dose of an RSV vaccine helps maintain protection in adults who have received a lung or kidney transplant. These patients are at high risk for severe RSV infection because their immune systems are weakened by anti-rejection medications…

This study aims to understand how common and severe Respiratory Syncytial Virus (RSV) infections are in older adults hospitalized in Vietnam. Researchers will observe 1,000 patients aged 60+ who are already in the hospital for breathing problems or heart/lung disease flare-ups. T…